Table 1.
Athletes with screening abnormalities (n = 494) | |
---|---|
n (%) | |
Baseline characteristics | |
Male | 396 (80.2) |
Age, mean (range) in years | 47.9 (36–79) |
Ethnicity | |
Caucasian | 488 (98.8) |
African/Afro-Caribbean | 3 (0.6) |
Other | 3 (0.6) |
Level of competition | |
Elite (national/international competition) | 7 (1.4) |
Competitive | 249 (50.4) |
Recreational | 238 (48.2) |
>6 weekly training hours | 283 (57.3) |
Screening abnormalities (Lausanne protocol) | |
History | 415 (84.0) |
Exercise-related complaintsa | 381 (77.1) |
Chest discomfort | 111 (22.5) |
Dyspnoea | 93 (18.8) |
Palpitations | 103 (20.8) |
Dizziness or fainting | 32 (6.5) |
Syncope | 59 (11.9) |
Abnormal fatigue | 202 (40.9) |
History of any CC | 74 (15.0) |
Family history SCA/SCD, inherited or congenital CC | 165 (33.4) |
Physical examination | 155 (31.4) |
Hypertension (>140/90 mm Hg) | 70 (14.2) |
Cardiac murmur | 96 (19.4) |
Peripheral vascular disease | 3 (0.6) |
Pectus excavatum | 9 (1.8) |
Resting 12-lead ECG | |
ESC-2005 criteria | 308 (62.3) |
CC: cardiovascular conditions; ECG: electrocardiogram; ESC: European Society of Cardiology; HRCC: high-risk cardiovascular conditions; SCA: sudden cardia arrest; SCD: sudden cardiac death.
Athletes had one or more exercise-related complaint.